Providence First Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Providence First Trust's BMY Position: Q2 2026 in Review
Providence First Trust reduced its Bristol-Myers Squibb (BMY) stake by 42% in Q2 2026, selling an estimated $238K and leaving 5,695 shares worth $328K. The position accounts for 0.09% of the portfolio, ranked #178.
Providence First Trust first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $597K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Providence First Trust held 5,695 shares of Bristol-Myers Squibb worth $328K as of Q2 2026.
- Providence First Trust sold 4,144 Bristol-Myers Squibb shares in Q2 2026, an estimated $238K.
- Bristol-Myers Squibb made up 0.09% of Providence First Trust's portfolio in Q2 2026, its #178 holding.
- Providence First Trust first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Providence First Trust's Bristol-Myers Squibb position peaked at $597K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Providence First Trust's 13F filing for Q2 2026, filed 27 Jul 2026.